Same-day discharge following catheter ablation and venous closure with VASCADE MVP: A postmarket registry.
VASCADE MVP
atrial fibrillation
catheter ablation
patient-reported outcomes
same-day discharge
Journal
Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
revised:
08
11
2022
received:
13
09
2022
accepted:
25
11
2022
pubmed:
1
12
2022
medline:
11
2
2023
entrez:
30
11
2022
Statut:
ppublish
Résumé
Early and safe ambulation can facilitate same-day discharge (SDD) following catheter ablation, which can reduce resource utilization and healthcare costs and improve patient satisfaction. This study evaluated procedure success and safety of the VASCADE MVP venous vascular closure system in patients with atrial fibrillation (AF). The AMBULATE SDD Registry is a two-stage series of postmarket studies in patients with paroxysmal or persistent AF undergoing catheter ablation followed by femoral venous access-site closure with VASCADE MVP. Efficacy endpoints included SDD success, defined as the proportion of patients discharged the same day who did not require next-day hospital intervention for procedure/access site-related complications, and access site sustained success within 15 days of the procedure. Overall, 354 patients were included in the pooled study population, 151 (42.7%) treated for paroxysmal AF and 203 (57.3%) for persistent AF. SDD was achieved in 323 patients (91.2%) and, of these, 320 (99.1%) did not require subsequent hospital intervention based on all study performance outcomes. Nearly all patients (350 of 354; 98.9%) achieved total study success, with no subsequent hospital intervention required. No major access-site complications were recorded. Patients who had SDD were more likely to report procedure satisfaction than patients who stayed overnight. In this study, 99.7% of patients achieving SDD required no additional hospital intervention for access site-related complications during follow-up. SDD appears feasible and safe for eligible patients after catheter ablation for paroxysmal or persistent AF in which the VASCADE MVP is used for venous access-site closure.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
348-355Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Hosseini SM, Rozen G, Saleh A, et al. Catheter ablation for cardiac arrhythmias: utilization and in-hospital complications, 2000 to 2013. JACC Clin Electrophysiol. 2017;3:1240-1248.
Kowalski M, Parikh V, Salcido JR, et al. Same-day discharge after cryoballoon ablation of atrial fibrillation: a multicenter experience. J Cardiovasc Electrophysiol. 2021;32:183-190.
He H, Datla S, Weight N, et al. Safety and cost-effectiveness of same-day complex left atrial ablation. Int J Cardiol. 2021;322:170-174.
König S, Svetlosak M, Grabowski M, et al. Utilization and perception of same-day discharge in electrophysiological procedures and device implantations: an EHRA survey. Europace. 2021;23:149-156.
Deyell MW, Leather RA, Macle L, et al. Efficacy and safety of same-day discharge for atrial fibrillation ablation. JACC Clin Electrophysiol. 2020;6:609-619.
Jafry AH, Akhtar KH, Khan JA, et al. Safety and feasibility of same-day discharge for catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Interv Card Electrophysiol. 2022;62(3):803-811.
Rashedi S, Tavolinejad H, Kazemian S, et al. Efficacy and safety of same-day discharge after atrial fibrillation ablation: a systematic review and meta-analysis. Clin Cardiol. 2022;45:162-172.
Prasitlumkum N, Cheungpasitporn W, Chokesuwattanaskul R, et al. Comparison between same-day discharge and overnight stay after atrial fibrillation ablation: systematic review and meta-analysis. Pacing Clin Electrophysiol. 2021;44:2054-2066.
Mohanty S, Trivedi C, Beheiry S, et al. Venous access-site closure with vascular closure device vs. manual compression in patients undergoing catheter ablation or left atrial appendage occlusion under uninterrupted anticoagulation: a multicentre experience on efficacy and complications. Europace. 2019;21:1048-1054.
Natale A, Mohanty S, Liu PY, et al. Venous vascular closure system versus manual compression following multiple access electrophysiology procedures: the AMBULATE trial. JACC Clin Electrophysiol. 2020;6:111-124.
Cardiva Medical Inc. VASCADE® MVP venous vascular closure system (VVCS) instructions for use model 800-612C. Accessed November 23, 2020. https://www.accessdata.fda.gov/cdrh_docs/pdf12/P120016S024C.pdf
Al-Ahmad A, Mittal S, DeLurgio D, et al. Results from the prospective, multicenter AMBULATE-CAP trial: reduced use of urinary catheters and protamine with hemostasis via the Mid-bore Venous Vascular Closure system (VASCADE® MVP) following multi-access cardiac ablation procedures. J Cardiovasc Electrophysiol. 2021;32:191-199.
Arai H, Mizukami A, Hanyu Y, et al. Risk factors for venous bleeding complication at the femoral puncture site after catheter ablation of atrial fibrillation. J Arrhythm. 2020;36:678-684.
Reddy SA, Nethercott SL, Chattopadhyay R, Heck PM, Virdee MS. Safety, feasibility and economic impact of same-day discharge following atrial fibrillation ablation. Heart, Lung Circ. 2020;29:1766-1772.
Creta A, Ventrella N, Providência R, et al. Same-day discharge following catheter ablation of atrial fibrillation: a safe and cost-effective approach. J Cardiovasc Electrophysiol. 2020;31:3097-3103.
Steinberg BA, Woolley S, Li H, et al. Patient-reported outcomes and costs associated with vascular closure and same-day discharge following atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2022;33(8):1737-1744.
Bartoletti S, Mann M, Gupta A, et al. Same-day discharge in selected patients undergoing atrial fibrillation ablation. Pacing Clin Electrophysiol. 2019;42:1448-1455.
Opel A, Mansell J, Butler A, et al. Comparison of a high throughput day case atrial fibrillation ablation service in a local hospital with standard regional tertiary cardiac centre care. Europace. 2019;21:440-444.
Lakkireddy DR, Chung MK, Deering TF, et al. Guidance for rebooting electrophysiology through the COVID-19 pandemic from the heart rhythm society and the American Heart Association electrocardiography and arrhythmias committee of the Council on Clinical Cardiology. Circ Arrhythm Electrophysiol. 2020;13:e008999.
Rubin GA, Biviano A, Dizon J, et al. Performance of electrophysiology procedures at an academic medical center amidst the 2020 coronavirus (COVID-19) pandemic. J Cardiovasc Electrophysiol. 2020;31:1249-1254.
Akula ND, Mariam W, Luthra P, et al. Safety of same day discharge after atrial fibrillation ablation. J Atr Fibrillation. 2020;12:2150.
Thomas KL, Al-Khalidi HR, Silverstein AP, et al. Ablation versus drug therapy for atrial fibrillation in racial and ethnic minorities. J Am Coll Cardiol. 2021;78:126-138.